alexa Pregabalin Confers No Added Benefit to a Non-steroid Anti-inflammatory Drug and Acetaminophen Regimen in Outpatient Breast Cancer Surgery: A Randomized Controlled Trial
ISSN: 2155-6148

Journal of Anesthesia & Clinical Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Pregabalin Confers No Added Benefit to a Non-steroid Anti-inflammatory Drug and Acetaminophen Regimen in Outpatient Breast Cancer Surgery: A Randomized Controlled Trial

Ronald B. George1,2*, Dolores M. McKeen2, Colin Boyd J1,2 and Geoff A. Porter1,3

1IWK Health Centre, Dalhousie University, Canada

2Department of Women's & Obstetric Anesthesia, Dalhousie University, Canada

3Department of Surgery, Dalhousie University, Canada

*Corresponding Author:
Ronald B. George
IWK Health Centre, Department of Women’s & Obstetric Anesthesia
5850/5980 University Avenue, P.O. Box 9700, Halifax
NS, B3K 6R8, Canada, B3K 6R8
Tel: (902) 470-6627
Fax: (902) 470-6626
E-mail: [email protected]

Received date: January 20, 2014; Accepted date: February 17, 2014; Published date: February 19, 2014

Citation: George RB, McKeen DM, Boyd JC, Porter GA (2014) Pregabalin Confers No Added Benefit to a Non-steroid Anti-inflammatory Drug and Acetaminophen Regimen in Outpatient Breast Cancer Surgery: A Randomized Controlled Trial. J Anesth Clin Res 5:383. doi: 10.4172/2155-6148.1000381

Copyright: © 2014 George, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Objectives: Multimodal analgesia may reduce both postoperative pain and the risk of adverse effects associated with opioid-use. Pregabalin has emerged as a potential perioperative analgesic with an improved pharmacokinetic profile. However, data regarding its analgesic efficacy and optimal dose following breast surgeries are conflicting. This study was designed to determine if perioperative treatment with pregabalin could reduce pain scores and oxycodone consumption following elective surgery for possible breast cancer.

Methods: Fifty-nine women undergoing elective breast cancer surgery (mastectomies and lumpectomies) were recruited for this study. Patients were randomized to pregabalin (150 mg) or placebo, both administered prior to surgery and 12 hours postoperatively. Pain and nausea intensity were measured using an 11-point numerical rating scale 2, 24, and 48 h postoperatively. Acetaminophen, naprosyn, and oxycodone were available in both groups postoperatively.

Results: At 24 hours post-op there were no differences in average pain intensity at rest (placebo 1.3 vspregabalin 0.6; difference=0.65, 95% CI: -0.09 to 1.39, p=0.08), pain following movement (placebo 1.3 vs P150 1.2; difference=0.14, 95% CI: -0.59 to 0.88, p=0.70, or average oxycodone tablet consumption (placebo 0.7 vs P150 1.0, difference=0.26, 95% CI: -1.86 to 1.35, p=0.72) postoperatively.

Conclusion: Pregabalin given preoperatively and 12 h postoperatively did not improve pain or oxycodone consumption 24 h following breast surgery. Further research regarding the appropriate dose and timing of pregabalin administration surrounding breast surgery is required.

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version